Order results by:
Issue | Title | |
Vol 16, No 5 (2024) | Gidazepam – daytime tranquilizer for the treatment of anxiety | Abstract similar documents |
Yu. E. Azimova, D. S. Petelin | ||
"... Gidazepam is a benzodiazepine tranquilizer with several characteristic pharmacodynamic properties ..." | ||
Vol 11, No 1 (2019) | Tapering (deprescribing) of benzodiazepine tranquilizers | Abstract similar documents |
D. A. Sychev, A. V. Zhuchkov, O. V. Tereshchenko, D. V. Ivashchenko | ||
"... investigations demonstrating the tapering of benzodiazepine tranquilizers: comparison of simple tampering, use ..." | ||
Vol 12, No 3 (2020) | Memantine: procognitive and antinegative effects in mental illness (a literature review) | Abstract similar documents |
D. V. Romanov, P. G. Yuzbashyan | ||
Vol 12, No 2 (2020) | Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes | Abstract similar documents |
D. V. Ivashchenko, O. V. Tereshchenko, I. I. Temirbulatov, K. A. Akmalova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev | ||
"... Phenazepam is a benzodiazepine tranquilizer that is widely used in Russia. The drug is metabolized ..." | ||
Vol 10, No 1 (2018) | Cognitive impairment in anxiety disorders | Abstract similar documents |
B. A. Volel, D. S. Petelin, R. V. Akhapkin, A. A. Malyutina | ||
"... frequently used drugs (antidepressants, atypical antipsychotics, anticonvulsants, tranquilizers) does ..." | ||
Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
E. G. Mendelevich | ||
"... . A number of trials indicate that the use of benzodiazepines (such as phenazepam) may be considered ..." | ||
Vol 7, No 1 (2015) | Current therapy for chronic cerebrovascular attack | Abstract similar documents |
A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova | ||
"... drugs. Neuroleptics and tranquilizers are additionally administered in complex-pattern syndromes ..." | ||
Vol 13, No 6 (2021) | Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease | Abstract similar documents |
A. B. Lokshina, D. A. Grishina | ||
Vol 6, No 3 (2014) | Alcohol abuse and related disorders treatment of alcohol dependence | Abstract similar documents |
Yu. P. Sivolap | ||
"... . Benzodiazepines are the drugs of choice in alleviating alcohol withdrawal and preventing its convulsive attacks ..." | ||
Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
D. V. Romanov, B. A. Volel, D. S. Petelin | ||
"... a number of other effects, such as analgesic, anti-apathetic, anti-asthenic, procognitive, anxiolytic ..." | ||
Vol 13, No 2 (2021) | Anxiety and depression in COVID-19: treatment options | Abstract similar documents |
V. E. Medvedev | ||
"... of additional therapeutic procognitive and somatotropic properties, similar to those identified ..." | ||
Vol 8, No 2 (2016) | Effects of etifoxine: Chemoreactome simulation | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov | ||
"... compared with the reference drug lorazepam (benzodiazepine). Results and discussion. The data obtained ..." | ||
Vol 15, No 6 (2023) | Non-interventional epidemiological program for investigating the real-life practice of using quetiapine (Seroquel®) in patients with schizophrenia and bipolar affective disorder (EPIDEMICUS) | Abstract similar documents |
V. E. Medvedev, I. G. Kuznetsova | ||
"... , antipsychotic, antimanic and antidepressant effects, the drug also has antinegative, procognitive, anxiolytic ..." | ||
Vol 2, No 3 (2010) | Insomnia: clinical experience with Zolpidem (Sanval) | Abstract similar documents |
Ya. I. Levin | ||
"... and the minimization of administration of benzodiazepines are most important in pharmacotherapy for insomnia ..." | ||
Vol 15, No 3 (2023) | Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies | Abstract PDF (Eng) similar documents |
M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy | ||
"... in the treatment of anxiety disorders is comparable to that of benzodiazepine drugs. Tenoten has no inhibitory ..." | ||
Vol 16, No 5 (2024) | Muscle relaxers in acute musculoskeletal back pain | Abstract similar documents |
A. Kh. Mukhametzyanova, A. I. Isaikin | ||
"... ) and muscle relaxers (MR). Most modern clinical guidelines recommend non-benzodiazepine MR as the treatment ..." | ||
Vol 13, No 4 (2021) | Treatment of antipsychotic-induced parkinsonism in schizophrenic patients | Abstract similar documents |
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
"... ; benzodiazepines; herbal preparations traditionally used for the prevention and correction of extrapyramidal ..." | ||
Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
"... (clozapine, quetiapine), benzodiazepines, muscle relaxants (baclofen), and dopamine reuptake inhibitors ..." | ||
Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
M. V. Zamergrad, S. V. Morozova | ||
"... (antihistamines, benzodiazepines, and calcium antagonists) and antiemetics (dopamine antagonists and serotonin 5 ..." | ||
Vol 8, No 4 (2016) | NEUROTROPHIC EFFECTS OF ETIFOXINE | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, V. A. Semenov, O. A. Limanova, I. V. Gogoleva | ||
"... neurotransmitter receptors than is shown by benzodiazepines. Etifoxine has been also found to have anti ..." | ||
Vol 9, No 2 (2017) | Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova | ||
"... , increase its levels, inhibit benzodiazepine receptor and dopamine reuptake, and enhance neuronal ..." | ||
Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
A. A. Kholin | ||
"... is a rational alternative to benzodiazepines in SE in infancy, especially in cases of bulbar innervation ..." | ||
1 - 22 of 22 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)